Pneumoconiosis Treatment Guidelines Can Include a Variety of Therapies for Symptom Control

Pneumoconiosis treatment guidelines often include a combination of medications, supplemental oxygen and pulmonary rehabilitation to help alleviate the symptoms of the condition. People with pneumoconiosis may also be advised to maintain a healthy weight, stop smoking and/or avoid secondhand smoke and participate in regular exercise. Yearly flu vaccinations are also recommended to help reduce the likelihood of flu-related respiratory complications.

Another option that some people should consider is cellular therapy, a treatment in which a patient’s own cells are removed from their blood or bone marrow and then reintroduced intravenously in a concentrated infusion. While not capable of curing pneumoconiosis, cellular therapys have the potential to help slow the progression of the disease – something that many other therapies recommended by pneumoconiosis treatment guidelines cannot achieve. Cellular therapies may also help reduce inflammation and promote the body’s natural healing process.

At the Lung Institute, we perform stem cell procedures for patients with lung diseases such as pneumoconiosis. Our treatments are offered on an outpatient basis over the course of two days, and patients can return to their lives without a long or complicated recovery process. Other beneficial factors of undergoing cellular therapy at the Lung Institute include our:

  • Singular focus on pulmonary diseases – We are the only cellular therapy center in the world to solely focus on conditions affecting the lungs.
  • Patient-centric follow-up care – Our physicians work hand-in-hand with our patients’ pulmonologists and primary care providers to ensure that all pneumoconiosis treatment guidelines are carefully followed, and that each patient receives comprehensive, streamlined care.
  • State-of-the-art treatment facilities – The Lung Institute has clean and comfortable clinics with several convenient locations across the United States.

For more information about pneumoconiosis treatment guidelines and whether cellular therapy may be an appropriate addition to your treatment plan, call the Lung Institute at (800) 729-3065. We have an experienced and caring team that can answer your questions and potentially help you find the relief you need.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.